You have 9 free searches left this month | for more free features.

Takayasu Arteritis (TAK)

Showing 1 - 25 of 464

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Takayasu Arteritis Trial in Japan (Ustekinumab, Placebo, Glucorticoid Taper Regimen)

Recruiting
  • Takayasu Arteritis
  • Bunkyo-Ku, Japan
  • +28 more
Aug 16, 2022

Takayasu Arteritis (TAK) Trial in Worldwide (Upadacitinib, Placebo for Upadacitinib, Prednisolone)

Recruiting
  • Takayasu Arteritis (TAK)
  • Salvador, Bahia, Brazil
  • +44 more
Aug 22, 2022

Takayasu Arteritis Complicated With Pulmonary Artery Involvement

Recruiting
  • Takayasu Arteritis With Pulmonary Artery Involvement
  • +2 more
  • Percutaneous transluminal pulmonary angioplasty
  • Beijing, China
    Fuwai Hospital, National Center for Cardiovascular Diseases, Chi
Jan 9, 2023

Takayasu Arteritis Trial in Paris (UltraFast ultrasound)

Completed
  • Takayasu Arteritis
  • UltraFast ultrasound
  • Paris, France
    Hôpital Européen Georges Pompidou
Mar 22, 2022

Takayasu Arteritis Trial in China (MMF, CYC, Glucocorticoids)

Active, not recruiting
  • Takayasu Arteritis
  • Shijiazhuang, Hebei, China
  • +6 more
Feb 26, 2022

Takayasu Arteritis Trial in Shanghai (Tofacitinib, Methotrexate)

Recruiting
  • Takayasu Arteritis
  • Shanghai, Shanghai, China
    Lindi Jiang
Oct 19, 2021

Takayasu Arteritis, Tocilizumab, Adalimumab Trial in Shanghai (Tocilizumab, Adalimumab)

Recruiting
  • Takayasu Arteritis
  • +3 more
  • Tocilizumab
  • Adalimumab
  • Shanghai, Shanghai, China
    Department of Rheumatology in Zhongshan hospital, Fudan Universi
Aug 7, 2021

PET Imaging of Giant Cell and Takayasu Arteritis

Active, not recruiting
  • Giant Cell Arteritis
  • Takayasu Arteritis
  • PET-MRI
  • Cambridge, Cambridgeshire, United Kingdom
  • +1 more
Jul 31, 2022

Takayasu Arteritis Trial in Beijing (Tofacitinib 5 MG, Prednisolone, Placebo of tofacitinib 5mg)

Recruiting
  • Takayasu Arteritis
  • Tofacitinib 5 MG
  • +3 more
  • Beijing, China
    Peking Union Medical College Hospital
Feb 19, 2023

Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

Recruiting
  • Takayasu's Arteritis
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Takayasu Arteritis Trial in China (Leflunomide 10mg Tab, Prednisone Acetate, Placebos)

    Recruiting
    • Takayasu Arteritis
    • Leflunomide 10mg Tab
    • +2 more
    • Beijing, Beijing, China
    • +6 more
    Jun 25, 2022

    Takayasu Arteritis Trial in Beijing (Adalimumab Injection, Tofacitinib 5 MG)

    Recruiting
    • Takayasu Arteritis
    • Adalimumab Injection
    • Tofacitinib 5 MG
    • Beijing, China
    • +3 more
    Feb 26, 2022

    Individuals With Takayasu's Arteritis

    Completed
    • Takayasu's Arteritis
      • Boston, Massachusetts
      • +8 more
      Jul 11, 2022

      One-Time DNA Study for Vasculitis

      Recruiting
      • Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
      • +5 more
        • Los Angeles, California
        • +13 more
        May 16, 2022

        Armenian NAtionwide REGistry of Systemic Autoimmune and

        Not yet recruiting
        • Behcet Disease
        • +8 more
        • Usual medical management of patients, blood and stool samples for biobanking
        • Yerevan, Armenia
        • +1 more
        Jun 13, 2023

        The Registry Study of Takayasu Arteritis in East China

        Recruiting
        • Takayasu Arteritis
        • +4 more
        • Shanghai, Shanghai, China
          Department of Rheumatology in Zhongshan hospital, Fudan Universi
        Aug 7, 2021

        VCRC Tissue Repository

        Recruiting
        • Aortitis
        • +10 more
          • Boston, Massachusetts
          • +7 more
          Jan 25, 2022

          Physical Activity, Takayasu Arteritis Trial in Sao Paulo (Combined acute physical exercises (strength and aerobic))

          Completed
          • Physical Activity
          • Takayasu Arteritis
          • Combined acute physical exercises (strength and aerobic)
          • Sao Paulo, Brazil
            Samuel Katsuyuki Shinjo
          Apr 29, 2021

          Takayasu Arteritis, Methotrexate, Inhibition Trial in Shanghai (Methotrexate Tablets, Tofacitinib tablet)

          Recruiting
          • Takayasu Arteritis
          • +3 more
          • Methotrexate Tablets
          • Tofacitinib tablet
          • Shanghai, China
            Lindi Jiang
          Jun 10, 2020

          TAKAYASU ARTERITIS Trial in Saint-Antoine (Tocilizumab)

          Completed
          • TAKAYASU ARTERITIS
          • Saint-Antoine, Paris, France
            Department of internal medicine
          Aug 17, 2020

          Giant Cell Arteritis, Takayasu Arteritis, Cogan Syndrome Trial in Cambridge, Glasgow, London (Rituximab, Infliximab,

          Recruiting
          • Giant Cell Arteritis
          • +8 more
          • Rituximab
          • +2 more
          • Cambridge, United Kingdom
          • +2 more
          Dec 9, 2021

          Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis Trial in United States

          Recruiting
          • Eosinophilic Granulomatosis With Polyangiitis (EGPA)
          • +6 more
          • Naltrexone Hydrochloride
          • Placebo Comparator
          • Boston, Massachusetts
          • +6 more
          Jan 25, 2022

          Takayasu Arteritis Trial (Infliximab, Tocilizumab)

          Not yet recruiting
          • Takayasu Arteritis
          • (no location specified)
          Sep 21, 2020

          Wegeners Granulomatosis (Granulomatosis With Polyangiitis), Microscopic Polyangiitis, Churg Strauss Syndrome (Eosinophilic

          Recruiting
          • Wegeners Granulomatosis (Granulomatosis With Polyangiitis)
          • +6 more
            • San Francisco, California
            • +37 more
            Nov 4, 2022

            Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

            Completed
            • SCAD
            • +28 more
              • Rochester, Minnesota
                Mayo Clinic
              Nov 20, 2020